This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited bioavailability. Nanocarriers like liposomes and nanoparticles improve TCM delivery, offering greater therapeutic effectiveness and reduced side effects, but face challenges in biocompatibility and stability for clinical use.
The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing – Pharmaceutical Technology
SHL Medical’s in-house automation equipment program enables increased flexibility and scalability for autoinjector testing, assembly, and final assembly. Credit: SHL Medical. The drug delivery device